163 related articles for article (PubMed ID: 29062237)
1. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia.
Song YH; Peng P; Qiao C; Zhang R; Li JY; Lu H
Onco Targets Ther; 2017; 10():4917-4924. PubMed ID: 29062237
[TBL] [Abstract][Full Text] [Related]
2. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
[TBL] [Abstract][Full Text] [Related]
3. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
Zhang Y; Wu S; Luo D; Zhou J; Li D
PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between D-Dimer/Fibrinogen Ratio and Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Li SS; Yang XW; Zheng Y; Gao YJ; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1340-1344. PubMed ID: 37846682
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
6. [Abnormality of blood coagulation indexes in patients with de novo acute leukemia and its clinical significance].
Xiao FF; Hu KX; Guo M; Qiao JH; Sun QY; Ai HS; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):300-4. PubMed ID: 23628020
[TBL] [Abstract][Full Text] [Related]
7. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
8. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
Li S; Gao Y; Li F; Zheng Y; Su Y
Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
[TBL] [Abstract][Full Text] [Related]
9. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
10. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
[TBL] [Abstract][Full Text] [Related]
11. Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia.
Wen J; Xu F; Zhou Q; Shi L; Liu Y; Yue J; Zhang Y; Liang X
Front Oncol; 2022; 12():895777. PubMed ID: 36185183
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Zhao SX; Ge YY; Li ZZ; He HP; Shen CM; Shi KQ; Yang TH; DU YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
[TBL] [Abstract][Full Text] [Related]
14. [FLT3-ITD Mutation in Newly Diagnosed Patients with Acute Promyelocytic Leukemia].
Gong BF; Wang Y; Lin D; Wei H; Li W; Zhou CL; Liu BC; Liu KQ; Zhang GJ; Liu YT; Li Y; Wei SN; Gong XY; Zhao XL; Qiu SW; Gu RX; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1615-1621. PubMed ID: 28024465
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
[TBL] [Abstract][Full Text] [Related]
16. Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.
Gill H; Kumana CR; Yim R; Hwang YY; Chan TSY; Yip SF; Lee HKK; Mak V; Lau JSM; Chan CC; Kho B; Wong RSM; Li W; Lin SY; Lau CK; Ip HW; Leung RYY; Lam CCK; Kwong YL
Cancer; 2019 Sep; 125(17):3001-3012. PubMed ID: 31090936
[TBL] [Abstract][Full Text] [Related]
17. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia.
Cui W; Wang J; Nie RM; Zhao LL; Gao MQ; Zhu HM; Chen L; Hu J; Li JM; Shen ZX; Wang ZY; Chen SJ; Chen Z; Wang KK; Xi XD; Mi JQ
Eur J Haematol; 2018 Apr; 100(4):344-350. PubMed ID: 29266395
[TBL] [Abstract][Full Text] [Related]
19. Central venous catheters do not increase the hemorrhagic risk in acute promyelocytic leukemia patients during induction therapy.
Cao M; Hong J; Zhang D; Chen F; Su Y
Front Oncol; 2024; 14():1332372. PubMed ID: 38680857
[TBL] [Abstract][Full Text] [Related]
20. Predictors of early hemorrhage in acute promyelocytic leukemia.
Naymagon L; Moshier E; Tremblay D; Mascarenhas J
Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
